From: The Role of the New β-Blockers in Treating Cardiovascular Disease Am J Hypertens. 2005;18(S6):169S-176S. doi: /j.amjhyper Am J.

Slides:

Advertisements

Similar presentations

The role of lercanidipine in the treatment of hypertension:

Advertisements

Randall M. Zusman, MD Associate Professor of Medicine

s[1] u 1 /c 1 (1) c 1 (2) s[2] u 2 /c 2 (1) c 2 (2) s[3] u 3 /c 3 (1) c 3 (2)

Adiponectin versus angiotensin II: Key pathological role of their misbalance.

The Evaluate Trial. Rationale and Design of the Eplerenone Combination Versus conventional Agents to Lower blood pressure on Urinary Antialbuminuric Treatment.

Increased placebo response in Hispanics vs non-Hispanics in nebivolol hypertension trials: A post-hoc pooled analysis Thomas D. Giles, Henry Punzi, Madhuja.

Estimated 24-h urinary excretion of sodium and composite of cardiovascular death.. Figure 3. Estimated 24-h urinary excretion of sodium and composite of.

Copyright © 2015 by the American Osteopathic Association.

Figure 1. Schedule of the study

Plots of clinic blood pressure (CBP) versus daytime ambulatory (ABP) and home bl.. Figure 1. Plots of clinic blood pressure (CBP) versus daytime ambulatory.

Figure 1. (A) Assay for sLOX-1 in plasma from patients with pre-eclampsia (PE) and matched normal pregnant (NP) controls (n = 6). (B) Assay for oxLDL in.

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

AT1 receptor blockade can result in the stimulation of the AT2 receptor. Figure 6. AT1 receptor blockade can result in the stimulation of the.

Pulmonary Hypertension Is Associated with Mortality and Cardiovascular Events in Chronic Kidney Disease Patients Am J Nephrol 2017;45: DOI: /

Figure 1. Interaction of perceived neighborhood satisfaction and crime in predicting systolic blood pressure. From: Multilevel Associations of Neighborhood.

“Directionality” issues can be complex Cardiovascular Disease Clonal Hematopoiesis Age Smoking Obesity/Diabetes Hypertension Dyslipidemia Heritable Risk.

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

,..,_ -, =.. t :: ;... t---aM 0 d -...c " ss ''- !j!j ! )

'. \s\s I. '.. '... · \ \ \,, I.

برنامه راهبردی پیشگیری و کنترل بیماری های قلبی عروقی

Strategies to Improve Adherence and Persistence in the Treatment of Hypertension.

Nat. Rev. Nephrol. doi: /nrneph

Sayed H. Naderi, BMedSci, Jonathan P. Bestwick, MSc, David S. Wald, MD

Step Care Therapy for Hypertension in Diabetic Patients

Next-Gen Psoriasis Therapies:

Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or ARB is suggested to treat hypertension.

Recognition, Pathogenesis, and Treatment of Different Stages of Nephropathy in Patients With Type 2 Diabetes Mellitus George L. Bakris, MD Mayo Clinic.

When is the Ross operation a good option to treat aortic valve disease? Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, Manjula Maganti, MSc

عوامل اجتماعی موثر بر سلامت

' '· \ ·' ,,,,

Shared Primacy of Sodium and Potassium on Cardiovascular Risk

Pulmonary hypertension in valve disease: A beast of the past?

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Resistant Hypertension and the Pivotal Role for Mineralocorticoid Receptor Antagonists: A Clinical Update 2016 Murray Epstein, MD, Daniel A. Duprez,

Application of a neuroscience research model to study neuroprotection in children with congenital heart disease Nobuyuki Ishibashi, MD, Richard A. Jonas,

How should we treat air leaks?

New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum Martin Czerny, MD, MBA The Journal.

Malcolm O. Perry, MD, Richard Kempczinski, MD

Hypertension After Kidney Transplant

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

A fairy tale future for Fontans: Fact or fable?

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Michael Lanuti, MD The Journal of Thoracic and Cardiovascular Surgery

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS

Commentary: What in the world is glial fibrillary acidic protein?

Taking UP the chronic pulmonary obstructive disease gauntlet

Comparative Superiority of ACE Inhibitors Over Angiotensin Receptor Blockers for People With CKD: Does It Matter? Dimitris Mavridis, PhD American Journal.

Functional tricuspid pathology: To treat or not to treat

This Month in AJKD American Journal of Kidney Diseases

Is Salt a Culprit or an Innocent Bystander in Hypertension

Juan Jesús Carrero, PhD American Journal of Kidney Diseases

American Journal of Kidney Diseases

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Apparently, size matters…in congenital heart disease and brain injury

Tricuspid annulus diameter does not predict the development of tricuspid regurgitation after mitral valve repair for mitral regurgitation due to degenerative.

The continuing challenge of congenital heart disease in China

The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids Paul.

Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or angiotensin receptor blocker (ARB) is.

Toward a more rational approach in treating type B aortic dissection

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

Toll-like receptor 4 inhibition attenuates ischemia-reperfusion injury in rats: Will it work in human beings? Chadrick E. Denlinger, MD The Journal.

Respect the aorta The Journal of Thoracic and Cardiovascular Surgery

β-Blocker Use for the Stages of Heart Failure

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

This Month in AJKD American Journal of Kidney Diseases

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

Carl L. Backer, MD, Bradley S. Marino, MD, MPP, MSCE

Vasopressin stimulation of V2 and V1a receptors can contribute to events that worsen cardiac function. [Reprinted from J Am Coll Cardiol, vol. 47, Schrier.

Presentation transcript:

From: The Role of the New β-Blockers in Treating Cardiovascular Disease Am J Hypertens. 2005;18(S6):169S-176S. doi: /j.amjhyper Am J Hypertens | © 2005 by the American Journal of Hypertension, Ltd.American Journal of Hypertension, Ltd. Nebivolol exhibits a greater degree of β1/β2-receptor selectivity compared with..